Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 21 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-11-14 4 S $48.50 $193,987 D/D (4,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-21 4 AS $48.57 $437,137 D/D (9,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-31 4 AS $48.62 $243,116 D/D (5,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-12-12 4 AS $50.00 $250,000 D/D (5,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-30 4 A $51.26 $46,547 D/D 908 252,159 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-04-29 4 A $51.26 $21,223 D/D 414 395,635 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-04 4 AS $52.24 $156,731 D/D (3,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-18 4 AS $54.00 $270,000 D/D (5,000) 167,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-22 4 AS $55.00 $550,000 D/D (10,000) 157,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-01-23 4 AS $55.22 $220,880 D/D (4,000) 153,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-02-04 4 AS $55.77 $111,532 D/D (2,000) 153,691 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-21 4 AS $56.19 $86,817 I/I (1,545) 47,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-02-27 4 S $56.46 $84,683 D/D (1,500) 120,401 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-08 4 D $56.78 $311,098 D/D (5,479) 189,756 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-22 4 AS $56.88 $56,876 I/I (1,000) 46,195 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-15 4 D $57.44 $283,294 D/D (4,932) 180,257 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-02-28 4 AS $58.00 $290,000 I/I (5,000) 18,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-05 4 OE $58.68 $593,406 I/I 10,000 43,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-01 4 AS $59.14 $59,140 D/D (1,000) 119,401 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-05-12 4 D $59.30 $270,823 D/D (4,567) 185,189 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-06-03 4 S $59.88 $59,876 D/D (1,000) 179,257 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-04 4 AS $60.00 $300,000 I/I (5,000) 13,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-03-26 4 AS $60.68 $728,147 I/I (12,000) 13,545 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-04 4 OE $60.72 $607,194 I/I 10,000 43,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-11-05 4 AS $62.36 $311,779 I/I (5,000) 45,740 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21  22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 21 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us